Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 1;3(4):812-8.
doi: 10.1177/193229680900300430.

Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus

Enrique Soto-Pedre  1 , Maria Concepcion Hernaez-Ortega, José Antonio Vázquez
Affiliations

Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus

Enrique Soto-Pedre et al. J Diabetes Sci Technol. .

Abstract

Background: We estimate safe screening intervals for sight-threatening diabetic retinopathy (STDR).

Methods: A 6-year retrospective follow-up study to review screening results of two cohorts of patients with diabetes mellitus (DM) was conducted; a cohort free of diabetic retinopathy (DR) and a cohort with mild nonproliferative diabetic retinopathy (NPDR) at baseline. Patients had been screened by means of a nonmydriatic retinal camera. Baseline age, sex, and diabetes characteristics were also collected. Statistical analysis was based on life-table method of risk estimation.

Results: A total of 286 patients with DM free of DR and 144 patients with mild NPDR at baseline were included in the study. For patients free of DR, the probability of remaining free of STDR was 97% (95% confidence interval [CI] 94-99%) at the end of the fourth year. In this cohort of patients, those with type 2 DM were more likely to progress to STDR than those who had type 1 DM (p < .01). For patients with mild NPDR, the probability of remaining free of STDR dropped to 94% (95% CI 88-97%) at the end of the second year, and it was still 100% at the end of the second year for those with a glycated hemoglobin level < or =7.5% at baseline (p < .05).

Conclusions: Screening at a 3-4 year interval for diabetes patients free of DR is safe because of their low risk of developing STDR. Patients with mild NPDR require screening at a 1 year interval, or at a 2 year interval with good metabolic control.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Probability of STDR-free survival by type of DM. Cohort of diabetes patients free of retinopathy at baseline (n = 286).
Figure 2.
Figure 2.
Probability of STDR-free survival by diabetes duration. Cohort of diabetes patients free of retinopathy at baseline (n = 286).
Figure 3.
Figure 3.
Probability of STDR-free survival by glycated hemoglobin level. Cohort of diabetes patients free of retinopathy at baseline (n = 286). HbA1c, glycated hemoglobin level.
Figure 4.
Figure 4.
Probability of STDR-free survival by type of DM. Cohort of diabetes patients with mild NPDR at baseline (n = 144).
Figure 5.
Figure 5.
Probability of STDR-free survival by diabetes duration. Cohort of diabetes patients with mild NPDR at baseline (n = 144).
Figure 6.
Figure 6.
Probability of STDR-free survival by glycated hemoglobin level. Cohort of diabetes patients with mild NPDR at baseline (n = 144). HbA1c, glycated hemoglobin level.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4):383–396. - PubMed
    1. Witkin SR, Klein R. Ophthalmologic care for persons with diabetes. JAMA. 1984;251(19):2534–2537. - PubMed
    1. Soto-Pedre E, Hernaez-Ortega MC, Piniés JA. Duration of diabetes and screening coverage for retinopathy among patients with type 2 diabetes. Ophthalmic Epidemiol. 2007;14(2):76–79. - PubMed
    1. Soto-Pedre E, Hernaez-Ortega MC. Screening coverage for diabetic retinopathy using a three-field digital non-mydriatic fundus camera. Prim Care Diabetes. 2008;2(3):141–146. - PubMed
    1. Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand. 2000;78(4):374–385. - PubMed

Publication types